Roche’s cobas Babesia Blood Test Receives the US FDA’s Approval for Donor Screening

Roche’s cobas Babesia Blood Test Receives the US FDA’s Approval for Donor Screening

Shots:

  • The US FDA has granted approval for Roche’s cobas Babesia Test on the cobas 6800/8800 Systems for individual blood donation testing following May 2019 FDA updated industry guidance recommending screening and testing for Babesia, thus reducing the risk of transmitting the parasite via transfusion
  • The approval follows the launch of the cobas Zika test, leading to an expansion of Roche’s menu of tests for the cobas 6800/8800 Systems for use in donor screening laboratories in the US
  • The cobas Babesia test detects parasite living in RBCs, enable to detect 4 species of Babesia and employs the new whole blood collection tube, simplifying preparation by consolidating steps within the tube itself providing an efficient solution for testing laboratories

Click here to­ read full press release/ article | Ref: Roche | Image: Cash